completed Cost-Effectiveness Analysis of OOO for the Treatment of OOO in Korea 목록 본문 PERIOD: 2017.01.01-2019.12.31 SPONSOR: Global Pharmaceutical Company based in Korea 이전글The Real World Evidence on Treatment Patterns, Effectiveness, and Safety in Nonvalvular Atrial Fibrillation Patients with Oral Anticoagulants in Korea 다음글Low-Density Lipoprotein Cholesterol (LDL-C) Goal Achievement in Hyperlipidemic Patients in South Korea